Sterling Financial Planning, Inc. Adma Biologics, Inc. Transaction History
Sterling Financial Planning, Inc.
- $289 Million
- Q2 2025
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
406Shares Held
195MCall Options Held
2.28MPut Options Held
1.57M-
Vanguard Group Inc Valley Forge, PA21.4MShares$358 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$312 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$215 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$202 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$99.1 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.29B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...